Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Lung cancer presents a major worldwide health problem, accounting for 10% of all cancers. The treatment for those patients with small cell lung cancer has been unsatisfactory, but combination chemotherapy administered with radiotherapy can effect a cure in a minority of patients. Intensification of chemotherapy can improve the cure rate, and there are now a variety of haemopoietic growth factors available to support this approach, as the principal toxicity of the drugs used today is bone marrow suppression. Strategies to protect the bone marrow are also in development and are likely to allow further dose intensification. Recently randomised trials have reported survival benefits for intensified treatments.


Journal article


Emerging Drugs

Publication Date





293 - 301